Hab Pharmaceuticals And Research Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1997.
1997 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Hab Pharmaceuticals And Research Limited

Hab Pharmaceuticals And Research Limited, a active public limited company, was established on 22 January 1997 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U99999MH1997PLC105340. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹4.15 Cr.

It upholds a compliant status. Employing 197 professional, Its leadership includes Madanan Raghavan Chulliparambil (Director), Renu Sanjiv Garg (Director), Sureshchandra Agrawal (Director). Past directors included Madanan Raghavan Chulliparambil, Renu Sanjiv Garg, Saurabh Krishnakumar Agarwal. It holds ₹29.08 Cr open charges and ₹57.45 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Peninsula Business Park, Tower A, Unit No. 301, 3Rd Floor, Ganpatrao Kadam Marg,Lower Parel, Mumbai, Maharashtra, 400013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U99999MH1997PLC105340

  • Registration Number

    105340

  • Incorporation Date

    22 January 1997

  • Authorized Capital

    ₹20.00 Cr

  • Paid-Up Capital

    ₹4.15 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 4.15 Cr
  • Company Age 29 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 29.08 Cr
  • Satisfied Charges ₹ 57.45 Cr
  • Revenue Growth **** 30.27%
  • Profit Growth **** 99.03%
  • Ebitda **** 95.18%
  • Net Worth 60.56%
  • Total Assets **** 32.03%
Company report

Hab Pharmaceuticals And Research Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hab Pharmaceuticals And Research Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Hab Pharmaceuticals And Research Limited?
Current Directors
Name Designation Appointment Date Status
Madanan Raghavan Chulliparambil Director 21 Aug 2021 Current
Renu Sanjiv Garg Director 01 Oct 2009 Current
Sureshchandra Agrawal Director 04 Oct 2004 Current
Krishnakumar Radharaman Agarwal Managing Director 22 Jan 1997 Current
Sanjiv Surajbhan Garg Whole-Time Director 22 Jan 1997 Current
Saurabh Krishnakumar Agarwal Whole-Time Director 27 Oct 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Additional Director 27 Sep 2010 Past
Pramod Abcsdd Additional Director 30 Sep 2008 Past
Pramod Abcsdd Director 08 Apr 2021 Past
Pramod Abcsdd Director 01 Jul 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hab Pharmaceuticals And Research.

Hab Pharmaceuticals And Research Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.27% increase. The company also saw a substantial improvement in profitability, with a 99.03% increase in profit. The company's net worth Soared by an impressive increase of 60.56%.

Hab Pharmaceuticals And Research revenue growth over time
Hab Pharmaceuticals And Research profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 30.27%
*******
*******
*******
*******
Revenue from Operations
*******
 30.16%
*******
*******
*******
*******
Total Assets
*******
 32.03%
*******
*******
*******
*******
Profit or Loss
*******
 99.03%
*******
*******
*******
*******
Net Worth
*******
 60.56%
*******
*******
*******
*******
EBITDA
*******
 95.18%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hab Pharmaceuticals And Research?

In 2024, Hab Pharmaceuticals And Research had a promoter holding of 97.71% and a public holding of 2.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹290,815,000.00

Satisfied Charges

₹574,462,000.00

Charges Breakdown by Lending Institutions
  • Others : 29.00 Cr
  • Bank Of Baroda : 0.08 Cr
Latest Charge Details
Date Lender Amount Status
08 Sep 2023 Others ₹29.00 Cr Open
02 May 2012 Bank Of Baroda ₹0.82 M Open
02 Feb 2023 Standard Chartered Bank ₹10.00 Cr Satisfied
19 Dec 2020 Yes Bank Limited ₹9.79 M Satisfied
14 Sep 2017 Others ₹1.43 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Hab Pharmaceuticals And Research?

Hab Pharmaceuticals And Research has a workforce of 197 employees as of Mar 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hab Pharmaceuticals And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hab Pharmaceuticals And Research's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hab Pharmaceuticals And Research
Recent Activity within the Organization
  • Annual General Meeting

    Hab Pharmaceuticals And Research Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 29.00 Cr registered on 08 Sep 2023 with Charge ID 100788786 was modified on 26 Jul 2024. was recorded as a recent event.

  • Balance Sheet

    Hab Pharmaceuticals And Research Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.

  • Charges

    The activity A charge registered on 19 Dec 2020 via Charge ID 100425114 with Yes Bank Limited was fully satisfied on 22 Mar 2024. was completed.

  • Charges

    A charge registered on 21 Mar 2014 via Charge ID 10515477 with Yes Bank Limited was fully satisfied on 22 Mar 2024. was recorded as a recent event.

  • Charges

    A charge registered on 08 Nov 2013 via Charge ID 10463486 with Yes Bank Limited was fully satisfied on 22 Mar 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hab Pharmaceuticals And Research Limited?

The CIN of Hab Pharmaceuticals And Research Limited is U99999MH1997PLC105340.

Where is Hab Pharmaceuticals And Research Limited headquartered?

Hab Pharmaceuticals And Research Limited is headquartered at Peninsula Business Park, Tower A, Unit No. 301, 3Rd Floor, Ganpatrao Kadam Marg,Lower Parel, Mumbai, Maharashtra, 400013.

When was Hab Pharmaceuticals And Research Limited incorporated?

Hab Pharmaceuticals And Research Limited was incorporated on 22 January 1997.

Who are the current directors of Hab Pharmaceuticals And Research Limited?

The current directors of Hab Pharmaceuticals And Research Limited are

What is the primary industry of Hab Pharmaceuticals And Research Limited?

The primary industry of Hab Pharmaceuticals And Research Limited is Manufacturing.

Is Hab Pharmaceuticals And Research Limited a listed company?

Hab Pharmaceuticals And Research Limited is unlisted.

What is the capital structure of Hab Pharmaceuticals And Research Limited?

The authorized capital of Hab Pharmaceuticals And Research Limited is ₹20.00 Cr, and the paid-up capital is ₹4.15 Cr.

What is the compliance status of Hab Pharmaceuticals And Research Limited?

The compliance status of Hab Pharmaceuticals And Research Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available